Notably, 87.5% of SCN1A variants in our cohort occurred de novo, consistent with global findings that 80%–90% of SCN1A variations arise de novo in DS patients (Depienne et al., 2009; Scheffer and Nabbout, 2019). The gene discussed is SCN1A; the disease is Dravet syndrome.